Han et al. demonstrated that lncRNA MALAT1 can suppress glioma progression through down-regulation of MMP2 and inactivation of MAPK/ERK pathway [32]; Chen et al. revealed that lncRNA MALAT1 promoted the activation of MAPK/ERK signaling pathway in N2a cells [33]. Here, MMP2 is linked to central nervous system cancer.